CH
CLEAN HARBORS INC (CLH)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 delivered revenue of $1.55B, diluted EPS of $2.21, and adjusted EBITDA of $320.2M; adjusted EBITDA margin expanded 100 bps YoY to 20.7% as ES pricing, productivity and disposal volumes offset macro softness in industrial and field services .
- Versus consensus, CLH missed on revenue ($1.549B vs $1.572B*) and EPS ($2.21 vs $2.39*); prior Q2 also missed revenue and modestly missed EPS, while Q1 beat EPS but modestly missed revenue* .
- FY25 guidance: adjusted EBITDA lowered to $1.155–$1.175B (midpoint $1.165B) while adjusted free cash flow raised to $455–$495M (midpoint $475M); D&A raised to $445–$455M reflecting stronger landfill performance .
- Strategic update: announced $210–$220M SDA unit to upgrade VTAE into 600N base oil (EBITDA run-rate $30–$40M, payback 6–7 years, launch 2028); buybacks of $50M in Q3; net leverage <2x and blended interest rate 5.3% provide balance sheet flexibility .
- Near-term stock drivers: estimate misses and guide-down on EBITDA vs strong FCF raise, high incineration utilization (92% ex-Kimble), PFAS momentum ($100–$120M revenue in 2025), and capital allocation optionality (M&A + internal projects) .
What Went Well and What Went Wrong
What Went Well
- ES segment achieved its 14th straight quarter of YoY margin improvement; ES adjusted EBITDA margin rose 120 bps to 26.8% on pricing, labor management, and network leverage .
- Disposal network KPIs were strong: incineration utilization 92% ex-Kimble (88% including ramping Kimble); landfill volumes up ~40% YoY; Technical Services revenue +12% on steady demand and projects .
- PFAS momentum and credibility strengthened: EPA-published study validates safe, cost-effective destruction at commercial scale; PFAS revenue expected at $100–$120M in 2025 (+20–25% YoY) .
- Cash generation: Q3 operating cash flow $302M and record adjusted FCF $230.6M; capital discipline with net CapEx down YoY; share repurchases of $50M; net debt/EBITDA <2x and blended interest 5.3% .
Selected management quotes:
- “ES segment achieved its 14th consecutive quarter of year-over-year improvement in Adjusted EBITDA margin… increased by 120 basis points to 26.8%.”
- “The study confirmed… our high-temperature incinerators can… safely destroy these forever chemicals… at a cost-effective commercial scale.”
What Went Wrong
- Industrial Services revenue declined ~4% YoY as chemical and refining customers deferred turnaround scope; Field Services revenue fell ~11% YoY with absence of medium-to-large response projects .
- Healthcare expense spike: elevated high-cost claims drove SG&A up and were a notable headwind; management is modifying plans to mitigate in 2026 .
- Estimate performance: Q3 missed revenue and EPS vs consensus; Q2 also missed both, while Q1 beat EPS but missed revenue* .
Financial Results
Consolidated P&L and Margins (Q1–Q3 2025)
Consensus vs Actuals (Q1–Q3 2025)
Values retrieved from S&P Global.
Segment Breakdown (Q3 2025 vs Q3 2024)
Operating and Cash KPIs (Q3 2025)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Our consolidated Adjusted EBITDA margin increased by 100 basis points… demonstrating the effectiveness of our pricing, the leverage in our network of permitted facilities, and cost-saving strategies.”
- “Incineration utilization remained high… 92% versus 89%… landfill volumes were up 40% from a year ago.”
- “This study… confirmed… our high-temperature incinerators can… safely destroy [PFAS]… at a cost-effective commercial scale… PFAS… $100 to $120 million in revenue this year, up 20% to 25% from a year ago.”
- “We dramatically lowered our waste oil collection costs… gathered 64 million gallons… increased our direct lubricant sales… to 9%… margin improvement.”
- “We… plan to construct… SDA… upgrade VTAE into… 600N base oil… total spend $210–$220 million… EBITDA… $30–$40 million… commercial launch… 2028.”
- “Operating cash flow of $302 million and… record adjusted free cash flow of $231 million… underscores the… cash generative nature of our business.”
- “We are revising our 2025 adjusted EBITDA guidance to… $1.155 billion to $1.175 billion… We are raising our full year adjusted free cash flow guidance to a midpoint of $475 million.”
Q&A Highlights
- Guidance drivers:
$15M midpoint takedown mainly from IS ($7M), Field Services ($4M), healthcare ($6M company-wide) . - Forward outlook: preliminary target of ~5% EBITDA growth in 2026, largely ES-driven, with industrial recovery aligned to spring turnarounds .
- Free cash flow conversion: long-term target ~40% of EBITDA; extraordinary organic investments (e.g., SDA) will be excluded from FCF reporting going forward .
- SDA underwriting: 600N pricing modeled conservatively; internal VTAE feedstock drives baseline; potential upside from third-party VTAE; disciplined, on-time/on-budget track record .
- Incineration pricing: mid-single-digit price growth across the population; SK branch ~8% growth; Field Services down ~9–11%; IS down ~3–4% .
- Healthcare costs: elevated high-cost claims in Q3; plan changes underway to temper in 2026; base trend still upward but not at Q3’s pace .
Estimates Context
- Q3 2025: Revenue $1.549B vs $1.572B*, EPS $2.21 vs $2.391* (miss). Q2 2025: Revenue $1.550B vs $1.592B*, EPS $2.36 vs $2.388* (miss). Q1 2025: Revenue $1.432B vs $1.441B* (miss), EPS $1.09 vs $1.052* (beat) .
- FY 2025 consensus: Revenue ~$6.00B*, EBITDA ~$1.164B*, EPS (normalized) ~7.25*, Target Price ~$252*; FY 2026 consensus: Revenue ~$6.23B*, EBITDA ~$1.229B*, EPS (normalized) ~8.00* [GetEstimates].
Values retrieved from S&P Global.
Detailed Estimates Tables
Values retrieved from S&P Global.
Key Takeaways for Investors
- Core disposal assets remain the earnings engine: high incineration utilization, strong landfill throughput, and pricing discipline continue to expand margins despite service-line softness .
- PFAS is a durable growth vector: scientific validation plus multi-offering “Total PFAS Solution” support rising revenues and a growing project pipeline .
- SKSS is stabilizing with CFO pricing and mix; near-term margin gains and FY25 ~$140M EBITDA target reduce volatility risk vs prior cycles .
- FY25 EBITDA guide-down is partially mitigated by a raised FCF outlook; cash generation enables continued internal investments (Kimble ramp, SDA) and opportunistic buybacks/M&A with low leverage .
- Healthcare cost spike and industrial turnaround deferrals are transitory risks; management is acting to mitigate healthcare expense and sees turnaround normalization by spring 2026 .
- Near-term trading lens: headline misses on revenue/EPS and EBITDA guide-down could pressure shares; watch for Q4 execution on disposal throughput, PFAS wins, and any updates on internal projects/M&A as potential positive catalysts .
- Medium-term thesis: network leverage, PFAS demand, reshoring tailwinds, and disciplined capital allocation (SDA, hubs, selective M&A) support multi-year EBITDA and FCF growth, with downside buffered by recurring waste flows across diversified verticals .
Appendix: Source Citations
- Q3 Press Release and 8-K: revenue, EPS, adjusted EBITDA, segment data, guidance, reconciliations .
- Q3 Earnings Call: segment commentary, PFAS study, SKSS metrics, capital allocation, OCF/FCF, D&A, healthcare costs, industrial/field services dynamics, pricing, Kimble ramp .
- Prior quarters PRs for trend/guidance baselines .